Empowered Funds’s Axsome Therapeutics AXSM Stock Holding History

Empowered Funds’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,997	Closed	-$3.55M	–	2129
2026 Q1	$3.55M	Buy	20,997 +19,695	+1,513%	+$3.4M	0.02%	799
2025 Q4	$238K	Buy	+1,302	New	+$182K	﹤0.01%	905

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Empowered Funds's AXSM Position: Q2 2026 in Review

Empowered Funds sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 20,997 shares — an estimated $3.55M sold.

Empowered Funds first reported a position in AXSM in Q4 2025 and held it in 2 quarters. The position peaked at $3.55M in Q1 2026. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Empowered Funds reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
Empowered Funds sold 20,997 Axsome Therapeutics shares in Q2 2026, an estimated $3.55M.
Empowered Funds first reported a position in Axsome Therapeutics in Q4 2025 and held it in 2 quarters.
Empowered Funds's Axsome Therapeutics position peaked at $3.55M in Q1 2026.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.